List of insiders holdings for Emergent BioSolutions Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time		Shares Owned
Directly
Indirectly		Total
Shares Owned		Filing
El-Hibri Fuad
Director		2021-12-07 21:10:111,136,971
3,706,442		4,843,413Form 4
Intervac L.L.C.
10% Owner		2012-09-20 20:20:014,494,250
0		4,494,250Form 4
Microscience Investments LTD
Member of 13(d) group
10% Owner		2007-03-16 14:18:243,636,801
0		3,636,801Form 13G
BIOPHARM L.L.C.
10% Owner		2010-06-01 16:12:282,965,043
0		2,965,043Form 4
Myers Robert Calvin
Member 13(d) group owning >10%		2007-02-14 12:43:522,394,045
0		2,394,045Form 13G
Biovac L.L.C.
13(d) group member, owns > 10%		2007-02-14 12:30:521,599,155
0		1,599,155Form 13G
JP MORGAN PARTNERS BHCA LP
JP MORGAN PARTNERS GLOBAL INVESTORS LP
J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN LP
J P MORGAN PARTNERS GLOBAL INVESTORS A LP
J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN II LP
JP MORGAN PARTNERS GLOBAL INVESTORS SELLDOWN LLP
JP MORGAN PARTNERS GLOBAL INVESTORS SELLDOWN II L P
JPMP MASTER FUND MANAGER L P
JPMP GLOBAL INVESTORS L P
JPMP CAPITAL CORP
Member of 13(d) group		2007-03-19 11:32:581,454,418
0		1,454,418Form 3
Biologika L.L.C.
Member 13(d) group owning >10%		2008-06-06 18:11:331,399,764
0		1,399,764Form 4
Michigan Biologic Products Inc.
Member 13(d) group owning >10%		2008-03-28 20:17:571,269,390
0		1,269,390Form 4
ADVENT PRIVATE EQUITY FUND III A LTD PARTNERSHIP
Member of 13(d) Group		2007-06-29 17:08:51925,537
0		925,537Form 13G
Intervac Management L.L.C.
13(d) group member, owns > 10%		2007-02-14 12:39:25719,275
0		719,275Form 13G
ARPI L.L.C.
13(d) group member, owns > 10%		2007-02-14 12:20:25658,254
0		658,254Form 13G
Mulligan Seamus
Director		2019-03-21 16:18:1256,141
545,590		601,731Form 4
Kramer Robert
President and CEO		2023-03-06 19:37:08551,933
0		551,933Form 4
Merlin General Partner II LTD (as General Partner of the Merlin Biosciences Fund L.P.)
Member of 13(d) group		2007-03-12 19:21:48498,722
0		498,722Form 3
ADVENT PRIVATE EQUITY FUND III B LTD PARTNERSHIP
Member of 13(d) Group		2007-03-12 19:58:34229,497
0		229,497Form 3
Havey Adam
EVP, Business Operations		2023-03-06 19:37:20213,226
0		213,226Form 4
LINDAHL RICHARD S
EVP, Chief Financial Officer		2023-03-06 19:36:21192,194
0		192,194Form 4
Fox Jennifer Lynne
EVP, Ext Aff, GC, Corp Sec		2023-03-06 19:35:58154,297
0		154,297Form 4
Glessner Coleen
EVP, Quality & Ethics, and CPL		2023-03-06 19:36:52151,017
0		151,017Form 4
Abdun-Nabi Daniel
CEO		2019-03-04 18:39:36142,617
1936		144,553Form 4
ADVENT PRIVATE EQUITY FUND III D LTD PARTNERSHIP
Member if a 13(d) Group		2007-03-12 20:00:49125,921
0		125,921Form 3
Arcuri Edward
COO		2007-05-10 11:04:35115,083
0		115,083Form 4
SARAN ATUL
EVP, Chief Strat & Dev Officer		2023-03-02 14:43:1286,645
0		86,645Form 4
ADVENT PRIVATE EQUITY FUND III C LTD PARTNERSHIP
Member of 13(d) Group		2007-03-12 19:59:4964,018
0		64,018Form 3
Strei Katherine
EVP, Chief HR Officer		2023-03-02 14:42:2362,824
0		62,824Form 4
SULLIVAN LOUIS W
Director		2022-05-31 16:15:1953,418
0		53,418Form 4
JOULWAN GEORGE A
Director		2022-05-31 16:20:5740,244
0		40,244Form 4
Keese Kyle
EVP, BioSciences Division		2011-03-17 15:31:4339,954
0		39,954Form 4
Elsey R Don
Chief Financial Officer		2012-03-16 15:06:1338,914
0		38,914Form 4
Harsanyi Zsolt
Director		2022-05-31 16:24:5338,052
0		38,052Form 4
Emergent BioSolutions Inc.
Sean Kirk, EVP, Manufacturing		2019-06-03 21:13:4336,624
0		36,624Form 3
Niederhuber John
Director		2016-05-23 08:39:3630,300
0		30,300Form 4/A
Merlin General Partner II LTD (as Managing Partner of the Merlin Biosciences Fund Gbr)
Member of 13(d) group		2007-03-12 19:19:1929,972
0		29,972Form 3
Chatfield Steven
EVP, BioSciences		2013-03-18 14:11:1328,000
0		28,000Form 4
Esposito Denise
CLO		2009-03-12 14:38:0027,300
0		27,300Form 4
Williams Paul Anthony
SVP, Products Business		2023-03-06 19:36:3725,837
0		25,837Form 4
Labinger Barry
EVP, Biosciences Div.		2015-11-17 17:15:4025,182
0		25,182Form 4
Bailey Sue
Director		2021-03-08 18:30:5624,427
0		24,427Form 4
Hauer Jerome M
Director		2022-05-31 16:22:5823,661
0		23,661Form 4
Richard Ronald
Director		2022-11-29 15:26:0519,837
0		19,837Form 4
Zoon Kathryn C
Director		2022-06-13 16:16:0919,654
0		19,654Form 4
ADVENT PRIVATE EQUITY FUND III GMBH & CO KG
Member of 13(d) Group		2007-03-12 20:08:2218,118
0		18,118Form 3
Kirk Sean
EVP, Manufacturing & Tech Ops		2021-04-01 18:54:1617,776
0		17,776Form 4
White Marvin L
Director		2022-05-31 16:18:5717,102
0		17,102Form 4
ADVENT PRIVATE EQUITY FUND III AFFILIATES
Member of 13 (d) Group		2007-03-12 20:01:4915,098
0		15,098Form 3
ALLBAUGH JOE M
Director		2008-05-23 10:13:4914,400
0		14,400Form 4
Malik Shahzad
Director		2007-06-18 19:15:1214,400
0		14,400Form 4
LOCKHART STEPHEN
SVP Product Development		2010-11-16 15:13:1112,813
0		12,813Form 4
Smith Karen L.
EVP, Chief Medical Officer		2021-05-11 16:30:1111,888
0		11,888Form 4
Dayal Sujata Tyagi
Director		2022-07-22 16:16:4611,852
0		11,852Form 4
Katkin Keith
Director		2022-04-05 16:22:498595
0		8595Form 4
ADVENT MANAGEMENT III L P
Member of 13(d) Group		2007-03-12 20:07:214530
0		4530Form 3
Zink Thomas
SVP & CMO		2007-05-21 15:41:581000
0		1000Form 4
APAX EUROPE IV GP CO LTD
Member of 13(d) group		2008-10-17 11:12:090
0		0Form 13G
Gibellini Mauro
SVP, Corporate Dev.		2007-06-06 15:10:320
0		0Form 4